Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

RHOFADE 1% CREAM

oxymetazoline hydrochloride
$23.4659per GM
High Outlier

Strength

10 mg/g

Manufacturer

Mayne Pharma

NDC

51862076530

Classification

Brand

Dosage Form

CREAM

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

OXYMETAZOLINE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA208552

On Market Since

10/24/2024

Pharmacological Classes

Imidazolines
Increased Sympathetic Activity
Vasoconstriction
Vasoconstrictor

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

+4.3%

1Y

+0.1%

3Y

N/A

5Y

N/A

All

+0.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

AFRIN 0.05% NASAL SPRAY
Brand
11523116705•Bayer HealthCare LLC
$0.2247
per ML
AFRIN 0.05% NASAL SPRAY
Brand
11523115901•Bayer HealthCare LLC
$0.3089
per ML
AFRIN 0.05% NASAL SPRAY
Brand
11523116703•Bayer HealthCare LLC
$0.3089
per ML
AFRIN 0.05% NASAL SPRAY
Brand
11523116706•Bayer HealthCare LLC
$0.3089
per ML
AFRIN NO DRIP PUMP MIST
Brand
11523178301•Bayer HealthCare LLC
$0.3443
per ML
AFRIN NO DRIP ORIG PUMP MIST
Brand
11523314201•Bayer HealthCare LLC
$0.3443
per ML
MUCINEX SINUS-MAX NASAL SPRAY
Brand
63824012011•RB Health (US) LLC
$0.3610
per ML
MUCINEX SINUS-MAX NASAL SPRAY
Brand
63824012917•RB Health (US) LLC
$0.3610
per ML
QSYMIA 3.75 MG-23 MG CAPSULE
Brand
62541020130•Vivus LLC
$5.7651
per EA
QSYMIA 7.5 MG-46 MG CAPSULE
Brand
62541020230•Vivus LLC
$5.9584
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy